HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: iovs.08-1724v1 50/1/441    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Glenn, J. V. Articles by Stitt, A. W. Search for Related Content PubMed PubMed Citation Articles by Glenn, J. V. Articles by Stitt, A. W.

Advanced Glycation End Product (AGE) Accumulation on Bruch’s Membrane: Links to Age-Related RPE Dysfunction

¹From the Centre for Vision and Vascular Science, School of Medicine, Dentistry and BioMedical Science, Queen’s University, Northern Ireland, United Kingdom; the ²Department of Anatomy and Cell Biology, University of Florida, Gainesville, Florida; the ³Department of Medical Biochemistry, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; and the ⁴School of Optometry and Visual Sciences, Cardiff University, Cathays, Cardiff, United Kingdom.

PURPOSE. Advanced glycation end products (AGEs) accumulate during aging and have been observed in postmortem eyes within the retinal pigment epithelium (RPE), Bruch’s membrane, and subcellular deposits (drusen). AGEs have been associated with age-related dysfunction of the RPE—in particular with development and progression to age-related macular degeneration (AMD). In the present study the impact of AGEs at the RPE-Bruch’s membrane interface was evaluated, to establish how these modifications may contribute to age-related disease.

METHODS. AGEs on Bruch’s membrane were evaluated using immunohistochemistry. A clinically relevant in vitro model of substrate AGE accumulation was established to mimic Bruch’s membrane ageing. Responses of ARPE-19 growing on AGE-modified basement membrane (AGE-BM) for 1 month were investigated by using a microarray approach and validated by quantitative (q)RT-PCR. In addition to identified AGE-related mRNA alterations, lysosomal enzyme activity and lipofuscin accumulation were also studied in ARPE-19 grown on AGE-BM.

RESULTS. Autofluorescent and glycolaldehyde-derived AGEs were observed in clinical specimens on Bruch’s membrane and choroidal extracellular matrix. In vitro analysis identified a range of dysregulated mRNAs in ARPE-19 exposed to AGE-BM. Altered ARPE-19 degradative enzyme mRNA expression was observed on exposure to AGE-BM. AGE-BM caused a significant reduction in cathepsin-D activity in ARPE-19 (P < 0.05) and an increase in lipofuscin accumulation (P < 0.01).

CONCLUSIONS. AGEs influence ARPE-19 mRNA expression profiles and may contribute to reduced lysosomal enzyme degradative capacity and enhanced accumulation of lipofuscin. Formation of AGEs on Bruch’s membrane may have important consequences for age-related dysfunction of the RPE, perhaps leading to age-related outer retinal disease.

This article has been cited by other articles:

				W.-L. Liao and I. V. Turko Accumulation of Large Protein Fragments in Prematurely Senescent ARPE-19 Cells Invest. Ophthalmol. Vis. Sci., October 1, 2009; 50(10): 4992 - 4997. [Abstract] [Full Text] [PDF]

				J. Ni, X. Yuan, J. Gu, X. Yue, X. Gu, R. H. Nagaraj, J. W. Crabb, and The Clinical Genomic and Proteomic AMD Study Group Plasma Protein Pentosidine and Carboxymethyllysine, Biomarkers for Age-related Macular Degeneration Mol. Cell. Proteomics, August 1, 2009; 8(8): 1921 - 1933. [Abstract] [Full Text] [PDF]